CONCLUSIONS Antihypertensive treatment reduces the risk of mortality and cardiovascular morbidity in people with diabetes mellitus and a systolic blood pressure more than 140 mm Hg .
If systolic blood pressure is less than 140 mm Hg , however , further treatment is associated with an increased risk of cardiovascular death , with no observed benefit
OBJECTIVE To assess the effect of antihypertensive treatment on mortality and cardiovascular morbidity in people with diabetes mellitus , at different blood pressure levels .
Blood pressure and risk of coronary heart disease: the Framingham study.
is well recognized that hypertensives are especially prone to clinical manifestations of atherosclerosis in general and to coronary heart disease ( CHD ) in particular . Prospect i ve epidemiologic investigation of the circumstances under which CHD evolves in hypertensives compared to their more normotensive cohorts has revealed a number of misconceptions concerning the nature of the relationship of blood pressure to atherosclerotic vascular disease . This report is concerned with a detailed examination of the relationship of  blood pressure  to the development of the various clinical manifestations of CHD  in each sex at varying ages . The
CONCLUSIONS Antihypertensive treatment reduces the risk of mortality and cardiovascular morbidity in people with diabetes mellitus and a systolic blood pressure more than 140 mm Hg .
If systolic blood pressure is less than 140 mm Hg , however , further treatment is associated with an increased risk of cardiovascular death , with no observed benefit
OBJECTIVE To assess the effect of antihypertensive treatment on mortality and cardiovascular morbidity in people with diabetes mellitus , at different blood pressure levels .